NVCA Today

Last year MedIC made a big footprint in Washington. Thanks to MedIC’s hard work, the venture capital industry and entrepreneurs have become a major stakeholder in the FDA reform debate and have helped change the focus of the debate from ensuring product safety to the importance of advancing medical innovation. We have also gained significant traction in moving our FDA reform goals forward. Click here for more details on MedIC’s accomplishments.

MedIC needs the support of all life science focused venture firms and companies more than ever! This is a critical year for our FDA reform efforts. Congress will be moving legislation to reauthorize the FDA user fee programs for drugs and medical devices, which expire in September.

Please join or renew your membership today and encourage your portfolio companies to join as well! Below are links to the membership forms:

Venture Firm Application
Portfolio Company Application 

Related articles:

• NVCA Will Accurately Define Venture Capital in This Election Year
• SOPA & PIPA – Likely More To Come
• Medical Device User Fees and FDA Reform Among Congress Priorities
• SBIR Legislation Signed Into Law
• Washington Clean-Energy Update